BibTex RIS Cite

SPOR FİZYOLOJİSİ BÖLÜMÜNE FAZLA KİLO YAKINMASI ile BAŞVURAN BİREYLERİN ANTROPOMETRİK ve BİYOKİMYASAL ÖZELLİKLERİ

Year 2014, Volume: 15 Issue: 1, 29 - 35, 01.04.2014

Abstract

AMAÇ: Bu çalışma, fazla kilo şikayeti ile polikliniğimize başvuran ve egzersiz reçetelendirmesi yapılan hastaların antropometrik ve bazı biyokimyasal değerlerini tespit etmek ve kilo durumuna göre ortaya çıkan farklılıkları göstermek amacıyla planlandı. GEREÇ ve YÖNTEM: 18-65 yaş arası 604 hastanın retrospektif olarak dosyaları incelenerek antropometrik ve biyokimyasal değerlere ulaşıldı. Bioimpedans yöntemi ile vücut kompozisyonları ölçülmüş olan (Tanita BC418) hastalar vücut kitle indekslerine göre (VKİ) Grup 1 (VKİ=25-29,9) (n=125), grup 2 (VKİ=30-34,9) (n=191), grup 3 (VKİ=35-39,9) (n=133), grup 4 (VKİ>40) (n=155) olarak 4 gruba ayrıldı. İstatistiksel olarak P<0.05'den bulunan değerler anlamlı kabul edildi. BULGULAR: Polikliniğimize başvuran 604 hastanın sadece %7'si erkekti (n=45). Çalışma grubunun % 20,6'sı fazla kilolu (n=125), %31,6'sı tip 1 obez (n=191), %22'si tip 2 obez (n=133), %25,7'si tip 3 obez (n=155) olarak saptandı. Bu 4 grup arasında yağ yüzdesi (p<0,001), yağ ağırlığı (p<0,001), yağsız ağırlık (p<0,001), kilo (p<0,001), VKİ (p<0,001), HbA1c (p<0,001), açlık kan şekeri (p<0,001), trigliserid (p<0,001), kolesterol (p<0,019), HDL (p<0,001), LDL (p<0,011), insülin (p<0,001), HOMA (p<0,001) Vitamin D (p<0,05) değerlerinde istatistiksel olarak anlamlı farklılık bulundu. SONUÇ: Verilerin değerlendirilmesi sonucunda obezitenin her geçen gün daha da artan ciddi bir sağlık sorunu olara karşımıza çıktığı ve bir çok biyokimyasal parametreyi olumsuz yönde etkilediği saptandı

References

  • 1- Prevention and management of the global epidemic of obesity. Report of the WHO consultation on obesity (Geneva, June, 3–5, 1997). Geneva: WHO.
  • 2- Who Expert Consultation (2004). Appropriate BodyMass index for Asian populations and its implications for policy and intervention strategies. The Lancet, 157- 1 6 3 . w w w . w h o . i n t / b m i / i n d e x . j s p ? intropage=intro_3.Html. Erişim: 02.05.2009.
  • 3- The World Health Organisation. Preventing chronic disease: a vital investment: WHO global report. Geneva: WHO, 2005:56.
  • 4- Mercer SW, Tessier S. A qualitative study of general practitioners' and practice nurses' attitudes to obesity management in primary care. Health Bull (Edinb) 2001;59(4):248-53.
  • 5- Onat A, Keleş I, Sansoy V, Ceyhan K, Uysal O, Çetinkaya A, et al. Rising obesity indices in 10-year follow-up of Turkish men and women: Body mass index independent predictor of coronary events among men. Türk Kardiyoloji Derneği Arşivi 2001;29:430-6.
  • 6- Satman I, Alagöl F, Ömer B, Kalaça S, Tütüncü Y, Çolak N, et al. Türkiye diyabet, hipertansiyon, obezite ve endokrinolojik hastalıklar prevalans çalışması-II. TURDEP II: Ön sonuçlar. Kronik hastalıklar oturumu, 13. Ulusal Halk Sağlığı Kongresi, 18-22 Ekim 2010, İzmir.
  • 7- Hatemi H, Turan N, Arık N, Yumuk V. Türkiye obezite ve hipertansiyon çalışması (TOHTA). Endokrinolojide Yönelişler Dergisi 2002;11:1-16.
  • 8- T.C. Sağlık Bakanlığı Türkiye obezite ile mücadele programı ve ulusal eylem planı taslağı. 3. Taslak (2008- 2012).
  • 9- Sansoy V. Türk erişkinlerinde beden kitle indeksi, bel çevresi ve bel kalça oranları. In: Onat A, editör. TEKHARF yüzyıl dönümünde Türk erişkinlerinde koroner risk haritası ve koroner kalp hastalığı. Argos Matbaacılık, İstanbul, 2001:68-73.
  • 10- Satman I, Yılmaz T, Sengul A, et al. Population-based study of diabetes and risk characteristics in Turkey: Results of the Turkish diabetes epidemiology study (TURDEP). Diabetes Care 2002;25:1551-6.
  • 11- Onat A, Yıldırım B, Çetinkaya A, Aksu H, Keleş İ, Uslu N, Gürbüz N, Sansoy V. Erişkinlerimizde obezite ve santral obezite göstergeleri ve ilişkileri: 1990-98'de düşündürücü obezite artışı erkeklerde daha belirgin. Türk Kardiyoloji Arşivi 1999;27:209-17.
  • 12- Akbulut GÇ, Özmen MM, Besler HT. Obezite tanımı, saptanması, sınıflandırılması, nedenleri, kronik hastalıklarla ilişkisi ve tedavi yöntemleri. Bilim ve Teknik Dergisi 2007;2-3.
  • 13- Wadden AT, Stunkard JA. Obezite tedavi el kitabı türkçesi, 1.Baskı, And Yayıncılık, İstanbul, 2003.
  • 14- Satman İ, Dinççağ N, Karşıdağ K, Şengül A, Salman F, Sargın M, Salman S, Baştar İ, Tütüncü Y, Uygur S, Özcan C, Yılmaz T. TURDEP Group Yayını 2000; 50:1,142.
  • 15- Whitaker R, Wright J, Pepe M, et al. Predicting adult obesity from child hood and parent obesity. N Engl J Med 1997;337:869-73.
  • 16- Fuller N, Jebb SA, Goldberdg G. Inter-observer variability in the measurement of body composition. Eur J Clin Nutr 1991;45;43-9.
  • 17- National Institutes of Health, National Heart, Lung and Blood Institute: Clinical guidelines on the idenditfication, evaluation and treatment of overweight and obesity in adults-in evidence report. Obes Res 1998;6 (Suppl 2):51-209.
  • 18- Barbosa -Silva MC, Barros AJ, Post CL, Waitzberg DL, Heymsfield SB. Can bioelectrical impedance analysis identify malnutrition in preoperative nutrition assessment? Nutrition 2003;19:422-6.
  • 19- Edefonti A, Picca M, Damiani B, et al. Prevalence of malnutrition assessed by bioimpedance analysis and anthropometry in children on peritoneal dialysis. Perit Dial Int 2001;21:172-9.
  • 20- Nakanishi N, Nakamura K, Suzuki K, Matsuo Y, Tatara K. Associations of body mass index and percentage body fat by bioelectrical impedance analysis with cardiovascular risk factors in Japanese male office workers. Ind Health 2000;38:273-9.
  • 21- Faisy C, Rabbat A, Kouchakji B, Laaban JP. Bioelectrical impedance analysis in estimating nutritional status and outcome of patients with chronic obstructive pulmonary disease and acute respiratory failure. Intensive Care Med 2000;26:518-25.
  • 22- World Health Organization Expert Committee: Physical status: The use and interpretation of anthropometry. WHO Technical Report Series no. 854. Geneva, World Healt Organization, 1995.
  • 23- Akbaş F, Atmaca HU, Karadaş E, Yıldız İ, Ökten İN. Hastanemizde ilk kez kurulan bir birim olarak İstanbul Eğitim ve Araştırma Hastanesi obezite polikliniği ve 2 yıl sonundaki verilerimizin değerlendirilmesi. İstanbul Med J 2013;14:253-6.
  • 24- Schutz Y, Woringer V. Obesity in Switzerland: a critical assessment of prevalence in children and adults.Int J Obes Relat Metab Disord 2002 Sep;26 Suppl2:3-11.
  • 25- Marques-Vidal P, Llobet S, Carvalho Rodrigues JA, Halpern MJ. Cardiovascular risk factor levels in Portuguese students. Acta Cardiol 2001 Apr;56(2):97- 101. 26- Jakicic JM, Donnelly JE, Jawad AE, Jacobsen DJ, Gunderson SC, Pascale R. Association between blood lipids and different measures of body fat distributions: Effect of BMI and age. Int J Obes 1993; 17:131-7.
  • 27- Fouad MF, Rastam S, Ward KD, Maziak W. Prevalence of Obesity and Its Associated Factors in Allepo, Syria. Prev Control 2006;2:85-94.
  • 28- Schooling CM, Lam TH, Li TH, Ho SY, Chan WM. Obesity, Physical activity and mortality in a prospective Chinese elderly cohort. Arch Intern Med 2006;166:1498-1504.
  • 29- Onat A. Türkiye'de obezitenin kardiyovasküler hastalıklara etkisi. Türk Kardiyoloji Dergisi 2003;31:279-89.
  • 30- Deveci SE, Güler H, Demet M, Özmen E, Hekimsoy Z. Elazığ Emniyet Müdürlüğü kurum hekimliği polikliniğine başvuran polislerde obezite sıklığı. Fırat Üniversitesi Sağlık Bilgileri Dergisi 2004;18:223-8.
  • 31- Alkış E, Dereli FO, Bostancı M, Zencir M, Özşahin A. Denizlide bir tekstil fabrikasında çalışanlarda hipertansiyon ve obesite sıklığı. TTB Mesleki Sağlık ve Güvenlik Dergisi 2005;23:34-7.
  • 32- Çayır A, Atak N, Köse SK. Beslenme ve diyet kliniğine başvuranlarda obezite durumu ve etkili faktörlerin belirlenmesi. Ankara Üniversitesi Tıp Fakültesi Mecmuası 2011;64(1):13-9.
  • 33- Aktener A, Dülger H, Erkayhan G, Görmeli G, Kafadar F. Yarı kırsal bir bölgede 20-64 yaş üreme çağı ve menopoz sonrası kadınlarda şişmanlık sıklığı. Trakya Üniversitesi Tıp Fakültesi Dergisi 2006;23:119-26.
  • 34- Kır T, Kılıç S, Uçar M, Açıkel CH, Göçgeldi E, Oğur R. Erlerde obezite prevalansının ve etkileyen faktörlerin saptanması. Gülhane Tıp Dergisi 2004;46:219-25.
  • 35- Masharani U, German MS, Pancreatic hormones and diabetes mellitus, In: Gardner DG, Shoback D, editors. Greenspan's basic and clinical endocrinology, 8th ed. McGraw-Hill, New York, 2007:661-747.
  • 36- Keskin MK, Tatar BT, Ayar K, Çolpan G, Bilgili G, Ersoy C, İmamoğlu Ş. Diyabetik ve non–diyabetik kadınlarda dislipidemi için deden kitle indeksi ve bel çevresi ne kadar belirleyicidir? Uludağ Üniversitesi Tıp Fakültesi Dergisi 2009;35 (2):69-72.
  • 37- Altuntaş Y. İnsülin direnci ve ölçüm metodları. In: Yenigün M,editör. Her yönüyle diabetes mellitus. 2. Baskı. Nobel Tıp Kitabevleri, İstanbul, 2001:839-52. 38- Goldstein BJ. Insulin resistance as the core defect in Type 2 diabetes mellitus. Am J Cardiol 2002;90:3G- 10G.
  • 39- Davidson MH. Management of dyslipidemia in patients with complicated metabolic syndrome. Am J Cardiol 2005;96:22-5.
  • 40- Law MR, Wald NJ, Thompson SG. By how much and how quickly does reduction in serum cholesterol concentration lower risk of ischaemic heart disease? BMJ 1994;308:367-73.
  • 41- Park YW, Zhu S, Palaniappan L. The metabolic syndrome: prevalence and associated risk factor findings in the US population from the Third National Health and Nutrition Examination Survey, 1988-1994. Arch Intern Med 2003;163:427-36.
  • 42- Lewis GF, Steiner G. Acut effects of insulin in the control of VLDLproduction in human. Implication fort he insülin resistant state. Diabetes Care 1996;19:390-3.
  • 43- Eckel RH, Yost TJ, Jensen D. Alterations in lipoprotein lipase in insulin resistance. Int J Obes Relat Metab Disord 1995;19:16-21).
  • 44- Sansoy V. Dünyada ve Türkiye'de metabolik sendrom. 1. metabolik sendrom sempozyumu. Antalya, 2004:13- 15.
  • 45- Sarı R, Balcı MK, Altunbaş A, Karayalçın Ü. The effect of body weight and weight loss on thyroid volume and function in obese women. Clin Endocrinol 2003;59(2): 258-62.
  • 46- Altunoğlu E, Ülgen E, Müderrisoğlu C, Erdenen F, Boz M. Obezite ve tiroid fonksiyonları. İstanbul Tıp Dergisi 2009;1:225.
  • 47- Knudsen N, Laurberg P, Rasmussen LB, Bulow I, Perrild H, Ovesen L, Jørgensen T. Small differences in thyroid function may be important for body mass index and the occurrence of obesity in the population. J Clin Endocrinol Metab 2005 Jul;90(7):4019-24.
  • 48- Moulin de Moraes CM, Mancini MC, de Melo ME, Figueiredo DA, Villares SM, Rascovski A, Zilberstein B, Halpern A. Prevalence of subclinical hypothyroidism in a morbidly obese population and improvement after weight loss induced by Roux-en-Y gastric bypass. Obes Surg 2005;15:1287-91.
  • 49- Kiortis DN, Durack I, Turpin G. Effects of a lowcalorie diet on resting metabolic rate and serum triiodothyronine levels in obese children. Eur J Pediatr 1999;158:446-50.
  • 50- R e i n e h r T, d e S o u s a G , A n d l e r W. Hyperthyrotropinemia in obese children is reversible after weight loss and is not related to lipids. J Clin Endocrinol Metab 2006;91:3088-91.
  • 51- Tagliaferri M, Berselli ME, Calo G, Minocci A, Savia G, Petroni ML, Viberti GC, Liuzzi A. Subclinical hypothyroidism in obese patients: relation to resting energy expenditure, serum leptin, body composition, and lipid profile. Obes Res 2001;9:196-201.
  • 52- Chomard P, Vernhes G, Autissier N, Debry G. Serum concentrations of total T4, T3, reverse T3 and free T4, T3 in moderately obese patients. Hum Nutr Clin Nutr 1985;39:371-8.
  • 53- Matzen LE, Kvetny J, Pedersen KK. TSH, thyroid hormones and nuclear-binding of T3 in mononuclear blood cells from obese and non-obese women. Scand J Clin Lab Invest 1989;49:249 -53.
  • 54- Duntas L, Hauner H, Rosenthal J, Pfeiffer EF. Th y r o tr o p i n r e l e a si n g h o rmo n e (TR H ) immunoreactivity and thyroid function in obesity. Int J Obes 1991;15:83-7.
  • 55- Naslund E, Andersson I, Degerblad M, Kogner P, Kral JG, Rossner S, Hellström PM. Associations of leptin, insulin resistance and thyroid function with long-term weight loss in dieting obese men. J Intern Med 2000;248:299-308.
  • 56- Iacobellis G, Ribaudo MC, Zappaterreno A, Iannucci CV, Leonetti F. Relationship of thyroid function with body mass index, leptin, insulin sensitivity and adiponectin in euthyroid obese women. Clin Endocrinol (Oxf) 2005;62:487-91.
  • 57- Buscemi S, Verga S, Blunda G, Galluzo A. Influences of obesity and weight loss on thyroid hormones. A 3- 3,5-year follow-up study on obese subjects with surgical bilo-pancreatic by-pass. J Endocrinol Invest 1997;20:276-81.
  • 58- Feldt-Rasmussen U. Thyroid and leptin. Thyroid 2007;17:413-9.
  • 59- Zimmermann-Belsing T, Brabant G, Holst JJ, FeldtRasmussen U. Circulation leptin and thyroid dysfunction. Eur J Endocrinol 2003;149:257-71.
  • 60- Buffington C, Walker B, Cowan Jr GS, Scruggs D. Vitamin D deficiency in morbidly obese. Obes Surg 1993;3:421-4.
  • 61- Wortsman J, Matsuoka LY, Chen TC, Lu Z, Holick MF. Decreased bioavailability of vitamin D in obesity Am J Clin Nutr 2000;72:690-3.
  • 62- Arunabh S, Pollack S, Yeh J, Aloia JF. Body fat content and 25-hydroxyvitamin D levels in healthy women. J Clin Endocrinol Metab. 2003 Jan;88(1):157-61.
  • 63- Liel Y, Ulmer E, Shary J, Hollis BW, Bell NH. Low circulating vitamin D in obesity. Calcif Tissue Int 1988;43:199-201.
  • 64- Lumb GA, Mawer EB, Stanbury SW. The apparent vitamin D resistance of chronic renal failure: a study of the physiology of vitamin D in man. Am J Med 1971;50:421-44.

Anthropometric and Metabolic Parameters in Patients Who Applied the Sports Physiology Clinic Regarding Overweight Problems

Year 2014, Volume: 15 Issue: 1, 29 - 35, 01.04.2014

Abstract

Objective: This study was designed to investigate anthropometric / biochemical variables and to illustrate weight-related differences in outpatients who applied to our clinic for extra weight problems and received exercise prescriptions. Materials and Methods: The anthropometric and biochemical values were retro-respectively obtained of 604 adult outpatients (18-65 years old). They were divided into four groups according with their body mass index (BMI) values obtained using the bio-impedance method (Tanita BC418): Group 1-BMI 25-29.9 (n=125); Group 2-BMI 30-34.9 (n=191); Group 3-BMI 35-39.9 (n=133); Group 4-BMI >40 (n=155). Differences between variables were accepted to be significant if the p value was less than 0.05. Results: Only 7% of the outpatients of our clinic were males (n=45). Of the study group, 20.6% were heavy weight (n=125), 31.6% were obese Type I (n=191), 22% were obese Type II (n=133), 25.7% were obese Type III (n=155). There were significant differences between these group in the following values: percentage of fat (p<0.001), fat mass (p<0.001), fat free mass (p<0.001), weight (p<0.001), BMI (p<0.001), HbA1c (p<0.001), fasting blood glucose (p<0.001), triglyceride (p<0.001), cholesterol (p<0.019), HDL (p<0.001), LDL (p<0.011), insulin (p<0.001), HOMA (p<0.001) Vitamin D (p<0.05). Conclusion: It was concluded that obesity is a serious and growing health problem, and it negatively affects many o the biochemical parameters.

References

  • 1- Prevention and management of the global epidemic of obesity. Report of the WHO consultation on obesity (Geneva, June, 3–5, 1997). Geneva: WHO.
  • 2- Who Expert Consultation (2004). Appropriate BodyMass index for Asian populations and its implications for policy and intervention strategies. The Lancet, 157- 1 6 3 . w w w . w h o . i n t / b m i / i n d e x . j s p ? intropage=intro_3.Html. Erişim: 02.05.2009.
  • 3- The World Health Organisation. Preventing chronic disease: a vital investment: WHO global report. Geneva: WHO, 2005:56.
  • 4- Mercer SW, Tessier S. A qualitative study of general practitioners' and practice nurses' attitudes to obesity management in primary care. Health Bull (Edinb) 2001;59(4):248-53.
  • 5- Onat A, Keleş I, Sansoy V, Ceyhan K, Uysal O, Çetinkaya A, et al. Rising obesity indices in 10-year follow-up of Turkish men and women: Body mass index independent predictor of coronary events among men. Türk Kardiyoloji Derneği Arşivi 2001;29:430-6.
  • 6- Satman I, Alagöl F, Ömer B, Kalaça S, Tütüncü Y, Çolak N, et al. Türkiye diyabet, hipertansiyon, obezite ve endokrinolojik hastalıklar prevalans çalışması-II. TURDEP II: Ön sonuçlar. Kronik hastalıklar oturumu, 13. Ulusal Halk Sağlığı Kongresi, 18-22 Ekim 2010, İzmir.
  • 7- Hatemi H, Turan N, Arık N, Yumuk V. Türkiye obezite ve hipertansiyon çalışması (TOHTA). Endokrinolojide Yönelişler Dergisi 2002;11:1-16.
  • 8- T.C. Sağlık Bakanlığı Türkiye obezite ile mücadele programı ve ulusal eylem planı taslağı. 3. Taslak (2008- 2012).
  • 9- Sansoy V. Türk erişkinlerinde beden kitle indeksi, bel çevresi ve bel kalça oranları. In: Onat A, editör. TEKHARF yüzyıl dönümünde Türk erişkinlerinde koroner risk haritası ve koroner kalp hastalığı. Argos Matbaacılık, İstanbul, 2001:68-73.
  • 10- Satman I, Yılmaz T, Sengul A, et al. Population-based study of diabetes and risk characteristics in Turkey: Results of the Turkish diabetes epidemiology study (TURDEP). Diabetes Care 2002;25:1551-6.
  • 11- Onat A, Yıldırım B, Çetinkaya A, Aksu H, Keleş İ, Uslu N, Gürbüz N, Sansoy V. Erişkinlerimizde obezite ve santral obezite göstergeleri ve ilişkileri: 1990-98'de düşündürücü obezite artışı erkeklerde daha belirgin. Türk Kardiyoloji Arşivi 1999;27:209-17.
  • 12- Akbulut GÇ, Özmen MM, Besler HT. Obezite tanımı, saptanması, sınıflandırılması, nedenleri, kronik hastalıklarla ilişkisi ve tedavi yöntemleri. Bilim ve Teknik Dergisi 2007;2-3.
  • 13- Wadden AT, Stunkard JA. Obezite tedavi el kitabı türkçesi, 1.Baskı, And Yayıncılık, İstanbul, 2003.
  • 14- Satman İ, Dinççağ N, Karşıdağ K, Şengül A, Salman F, Sargın M, Salman S, Baştar İ, Tütüncü Y, Uygur S, Özcan C, Yılmaz T. TURDEP Group Yayını 2000; 50:1,142.
  • 15- Whitaker R, Wright J, Pepe M, et al. Predicting adult obesity from child hood and parent obesity. N Engl J Med 1997;337:869-73.
  • 16- Fuller N, Jebb SA, Goldberdg G. Inter-observer variability in the measurement of body composition. Eur J Clin Nutr 1991;45;43-9.
  • 17- National Institutes of Health, National Heart, Lung and Blood Institute: Clinical guidelines on the idenditfication, evaluation and treatment of overweight and obesity in adults-in evidence report. Obes Res 1998;6 (Suppl 2):51-209.
  • 18- Barbosa -Silva MC, Barros AJ, Post CL, Waitzberg DL, Heymsfield SB. Can bioelectrical impedance analysis identify malnutrition in preoperative nutrition assessment? Nutrition 2003;19:422-6.
  • 19- Edefonti A, Picca M, Damiani B, et al. Prevalence of malnutrition assessed by bioimpedance analysis and anthropometry in children on peritoneal dialysis. Perit Dial Int 2001;21:172-9.
  • 20- Nakanishi N, Nakamura K, Suzuki K, Matsuo Y, Tatara K. Associations of body mass index and percentage body fat by bioelectrical impedance analysis with cardiovascular risk factors in Japanese male office workers. Ind Health 2000;38:273-9.
  • 21- Faisy C, Rabbat A, Kouchakji B, Laaban JP. Bioelectrical impedance analysis in estimating nutritional status and outcome of patients with chronic obstructive pulmonary disease and acute respiratory failure. Intensive Care Med 2000;26:518-25.
  • 22- World Health Organization Expert Committee: Physical status: The use and interpretation of anthropometry. WHO Technical Report Series no. 854. Geneva, World Healt Organization, 1995.
  • 23- Akbaş F, Atmaca HU, Karadaş E, Yıldız İ, Ökten İN. Hastanemizde ilk kez kurulan bir birim olarak İstanbul Eğitim ve Araştırma Hastanesi obezite polikliniği ve 2 yıl sonundaki verilerimizin değerlendirilmesi. İstanbul Med J 2013;14:253-6.
  • 24- Schutz Y, Woringer V. Obesity in Switzerland: a critical assessment of prevalence in children and adults.Int J Obes Relat Metab Disord 2002 Sep;26 Suppl2:3-11.
  • 25- Marques-Vidal P, Llobet S, Carvalho Rodrigues JA, Halpern MJ. Cardiovascular risk factor levels in Portuguese students. Acta Cardiol 2001 Apr;56(2):97- 101. 26- Jakicic JM, Donnelly JE, Jawad AE, Jacobsen DJ, Gunderson SC, Pascale R. Association between blood lipids and different measures of body fat distributions: Effect of BMI and age. Int J Obes 1993; 17:131-7.
  • 27- Fouad MF, Rastam S, Ward KD, Maziak W. Prevalence of Obesity and Its Associated Factors in Allepo, Syria. Prev Control 2006;2:85-94.
  • 28- Schooling CM, Lam TH, Li TH, Ho SY, Chan WM. Obesity, Physical activity and mortality in a prospective Chinese elderly cohort. Arch Intern Med 2006;166:1498-1504.
  • 29- Onat A. Türkiye'de obezitenin kardiyovasküler hastalıklara etkisi. Türk Kardiyoloji Dergisi 2003;31:279-89.
  • 30- Deveci SE, Güler H, Demet M, Özmen E, Hekimsoy Z. Elazığ Emniyet Müdürlüğü kurum hekimliği polikliniğine başvuran polislerde obezite sıklığı. Fırat Üniversitesi Sağlık Bilgileri Dergisi 2004;18:223-8.
  • 31- Alkış E, Dereli FO, Bostancı M, Zencir M, Özşahin A. Denizlide bir tekstil fabrikasında çalışanlarda hipertansiyon ve obesite sıklığı. TTB Mesleki Sağlık ve Güvenlik Dergisi 2005;23:34-7.
  • 32- Çayır A, Atak N, Köse SK. Beslenme ve diyet kliniğine başvuranlarda obezite durumu ve etkili faktörlerin belirlenmesi. Ankara Üniversitesi Tıp Fakültesi Mecmuası 2011;64(1):13-9.
  • 33- Aktener A, Dülger H, Erkayhan G, Görmeli G, Kafadar F. Yarı kırsal bir bölgede 20-64 yaş üreme çağı ve menopoz sonrası kadınlarda şişmanlık sıklığı. Trakya Üniversitesi Tıp Fakültesi Dergisi 2006;23:119-26.
  • 34- Kır T, Kılıç S, Uçar M, Açıkel CH, Göçgeldi E, Oğur R. Erlerde obezite prevalansının ve etkileyen faktörlerin saptanması. Gülhane Tıp Dergisi 2004;46:219-25.
  • 35- Masharani U, German MS, Pancreatic hormones and diabetes mellitus, In: Gardner DG, Shoback D, editors. Greenspan's basic and clinical endocrinology, 8th ed. McGraw-Hill, New York, 2007:661-747.
  • 36- Keskin MK, Tatar BT, Ayar K, Çolpan G, Bilgili G, Ersoy C, İmamoğlu Ş. Diyabetik ve non–diyabetik kadınlarda dislipidemi için deden kitle indeksi ve bel çevresi ne kadar belirleyicidir? Uludağ Üniversitesi Tıp Fakültesi Dergisi 2009;35 (2):69-72.
  • 37- Altuntaş Y. İnsülin direnci ve ölçüm metodları. In: Yenigün M,editör. Her yönüyle diabetes mellitus. 2. Baskı. Nobel Tıp Kitabevleri, İstanbul, 2001:839-52. 38- Goldstein BJ. Insulin resistance as the core defect in Type 2 diabetes mellitus. Am J Cardiol 2002;90:3G- 10G.
  • 39- Davidson MH. Management of dyslipidemia in patients with complicated metabolic syndrome. Am J Cardiol 2005;96:22-5.
  • 40- Law MR, Wald NJ, Thompson SG. By how much and how quickly does reduction in serum cholesterol concentration lower risk of ischaemic heart disease? BMJ 1994;308:367-73.
  • 41- Park YW, Zhu S, Palaniappan L. The metabolic syndrome: prevalence and associated risk factor findings in the US population from the Third National Health and Nutrition Examination Survey, 1988-1994. Arch Intern Med 2003;163:427-36.
  • 42- Lewis GF, Steiner G. Acut effects of insulin in the control of VLDLproduction in human. Implication fort he insülin resistant state. Diabetes Care 1996;19:390-3.
  • 43- Eckel RH, Yost TJ, Jensen D. Alterations in lipoprotein lipase in insulin resistance. Int J Obes Relat Metab Disord 1995;19:16-21).
  • 44- Sansoy V. Dünyada ve Türkiye'de metabolik sendrom. 1. metabolik sendrom sempozyumu. Antalya, 2004:13- 15.
  • 45- Sarı R, Balcı MK, Altunbaş A, Karayalçın Ü. The effect of body weight and weight loss on thyroid volume and function in obese women. Clin Endocrinol 2003;59(2): 258-62.
  • 46- Altunoğlu E, Ülgen E, Müderrisoğlu C, Erdenen F, Boz M. Obezite ve tiroid fonksiyonları. İstanbul Tıp Dergisi 2009;1:225.
  • 47- Knudsen N, Laurberg P, Rasmussen LB, Bulow I, Perrild H, Ovesen L, Jørgensen T. Small differences in thyroid function may be important for body mass index and the occurrence of obesity in the population. J Clin Endocrinol Metab 2005 Jul;90(7):4019-24.
  • 48- Moulin de Moraes CM, Mancini MC, de Melo ME, Figueiredo DA, Villares SM, Rascovski A, Zilberstein B, Halpern A. Prevalence of subclinical hypothyroidism in a morbidly obese population and improvement after weight loss induced by Roux-en-Y gastric bypass. Obes Surg 2005;15:1287-91.
  • 49- Kiortis DN, Durack I, Turpin G. Effects of a lowcalorie diet on resting metabolic rate and serum triiodothyronine levels in obese children. Eur J Pediatr 1999;158:446-50.
  • 50- R e i n e h r T, d e S o u s a G , A n d l e r W. Hyperthyrotropinemia in obese children is reversible after weight loss and is not related to lipids. J Clin Endocrinol Metab 2006;91:3088-91.
  • 51- Tagliaferri M, Berselli ME, Calo G, Minocci A, Savia G, Petroni ML, Viberti GC, Liuzzi A. Subclinical hypothyroidism in obese patients: relation to resting energy expenditure, serum leptin, body composition, and lipid profile. Obes Res 2001;9:196-201.
  • 52- Chomard P, Vernhes G, Autissier N, Debry G. Serum concentrations of total T4, T3, reverse T3 and free T4, T3 in moderately obese patients. Hum Nutr Clin Nutr 1985;39:371-8.
  • 53- Matzen LE, Kvetny J, Pedersen KK. TSH, thyroid hormones and nuclear-binding of T3 in mononuclear blood cells from obese and non-obese women. Scand J Clin Lab Invest 1989;49:249 -53.
  • 54- Duntas L, Hauner H, Rosenthal J, Pfeiffer EF. Th y r o tr o p i n r e l e a si n g h o rmo n e (TR H ) immunoreactivity and thyroid function in obesity. Int J Obes 1991;15:83-7.
  • 55- Naslund E, Andersson I, Degerblad M, Kogner P, Kral JG, Rossner S, Hellström PM. Associations of leptin, insulin resistance and thyroid function with long-term weight loss in dieting obese men. J Intern Med 2000;248:299-308.
  • 56- Iacobellis G, Ribaudo MC, Zappaterreno A, Iannucci CV, Leonetti F. Relationship of thyroid function with body mass index, leptin, insulin sensitivity and adiponectin in euthyroid obese women. Clin Endocrinol (Oxf) 2005;62:487-91.
  • 57- Buscemi S, Verga S, Blunda G, Galluzo A. Influences of obesity and weight loss on thyroid hormones. A 3- 3,5-year follow-up study on obese subjects with surgical bilo-pancreatic by-pass. J Endocrinol Invest 1997;20:276-81.
  • 58- Feldt-Rasmussen U. Thyroid and leptin. Thyroid 2007;17:413-9.
  • 59- Zimmermann-Belsing T, Brabant G, Holst JJ, FeldtRasmussen U. Circulation leptin and thyroid dysfunction. Eur J Endocrinol 2003;149:257-71.
  • 60- Buffington C, Walker B, Cowan Jr GS, Scruggs D. Vitamin D deficiency in morbidly obese. Obes Surg 1993;3:421-4.
  • 61- Wortsman J, Matsuoka LY, Chen TC, Lu Z, Holick MF. Decreased bioavailability of vitamin D in obesity Am J Clin Nutr 2000;72:690-3.
  • 62- Arunabh S, Pollack S, Yeh J, Aloia JF. Body fat content and 25-hydroxyvitamin D levels in healthy women. J Clin Endocrinol Metab. 2003 Jan;88(1):157-61.
  • 63- Liel Y, Ulmer E, Shary J, Hollis BW, Bell NH. Low circulating vitamin D in obesity. Calcif Tissue Int 1988;43:199-201.
  • 64- Lumb GA, Mawer EB, Stanbury SW. The apparent vitamin D resistance of chronic renal failure: a study of the physiology of vitamin D in man. Am J Med 1971;50:421-44.
There are 62 citations in total.

Details

Other ID JA82VT99TV
Journal Section Research Article
Authors

Şule Bulur This is me

Serpil Çeçen This is me

Fatma Eren This is me

Publication Date April 1, 2014
Published in Issue Year 2014 Volume: 15 Issue: 1

Cite

EndNote Bulur Ş, Çeçen S, Eren F (April 1, 2014) Anthropometric and Metabolic Parameters in Patients Who Applied the Sports Physiology Clinic Regarding Overweight Problems. Meandros Medical And Dental Journal 15 1 29–35.